Lambert–Eaton myasthenic syndrome as an autoimmune calcium channelopathy
- 1 October 2004
- journal article
- review article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 322 (4) , 1347-1351
- https://doi.org/10.1016/j.bbrc.2004.08.040
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- HLA‐B8 in Patients with the Lambert‐Eaton Myasthenic Syndrome Reduces Likelihood of Associated Small Cell Lung CarcinomaAnnals of the New York Academy of Sciences, 2003
- Presynaptic neuronal antigens expressed by a small cell lung carcinoma cell lineJournal of Neuroimmunology, 2001
- Molecular determinants of Ca2+ channel function and drug actionTrends in Pharmacological Sciences, 1995
- An anti-peptide antibody specific for the class A calcium channel alpha 1 subunit labels mammalian neuromuscular junction.Proceedings of the National Academy of Sciences, 1994
- The naming of voltage-gated calcium channelsNeuron, 1994
- Lambert‐eaton myasthenic syndrome IgG depletes presynaptic membrane active zone particles by antigenic modulationAnnals of Neurology, 1988
- Lambert‐Eaton myasthenic syndrome: II. Immunoelectron microscopy localization of IgG at the mouse motor end‐plateAnnals of Neurology, 1987
- Paraneoplastic myasthenic syndrome IgG inhibits 45Ca2+ flux in a human small cell carcinoma lineNature, 1985
- Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse.The Journal of Physiology, 1983
- Calcium Spike Electrogenesis and Other Electrical Activity in Continuously Cultured Small Cell Carcinoma of the LungScience, 1981